PIONEER big data platform for prostate cancer: lessons for advancing future real-world evidence research.

Autor: Lawlor A; Transforming cancer OUtcomes through Research (TOUR), King's College London, London, UK. ailbhe.lawlor@kcl.ac.uk., Beyer K; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands., Russell B; Transforming cancer OUtcomes through Research (TOUR), King's College London, London, UK., Steinbeisser C; Collaborate Project Management, Munich, Germany., Bjartell A; Department of Translational Medicine, Lund University, Malmö, Sweden., De Meulder B; European Institute for Systems Biology & Medicine, Lyon, France., Omar MI; Academic Urology Unit, University of Aberdeen, Aberdeen, Scotland., Hulsen T; Data Science & AI Engineering, Philips, Eindhoven, the Netherlands.; Research Centre Innovations in Care, Rotterdam University of Applied Sciences, Rotterdam, the Netherlands., Butler J; Bayer AB, Medical Affairs Oncology, Stockholm, Sweden., N'Dow J; European Association of Urology, Guidelines Office, Arnhem, the Netherlands., Rivas JG; Department of Urology, Clínico San Carlos University Hospital, Madrid, Spain., Gandaglia G; Università Vita-Salute San Raffaele, Milan, Italy., Nicoletti R; Unit of Urological Robotic Surgery and Renal Transplantation, Careggi Hospital, University of Florence, Florence, Italy., Sakalis V; Department of Urology, Hippokrateion General Hospital of Thessaloniki, Thessaloniki, Greece., Smith EJ; European Association of Urology, Guidelines Office, Arnhem, the Netherlands., Maass M; ARTTIC Innovation GmbH, Munich, Germany., Zong J; Bayer Healthcare, Global Medical Affairs Oncology, Whippany, NJ, USA., Fullwood L; Pinsent Masons, Leeds, UK., Abbott T; Astellas Pharma, Inc, Northbrook, IL, USA., Tafreshiha A; The Hyve, Utrecht, The Netherlands., Papineni K; Astellas Pharma, Inc, Northbrook, IL, USA., Snijder R; Astellas Pharma, Inc, Northbrook, IL, USA., Horgan D; European Alliance for Personalized Medicine, Brussels, Belgium., Seager S; Analytics & AI, IQVIA, Reading, UK., Evans-Axelsson S; Bayer AB, Medical Affairs Oncology, Stockholm, Sweden., Ribal MJ; European Association of Urology, Guidelines Office, Arnhem, the Netherlands., Roobol MJ; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands., Van Hemelrijck M; Transforming cancer OUtcomes through Research (TOUR), King's College London, London, UK.

Publikováno v: Nature reviews. Urology [Nat Rev Urol] 2024 Sep 09. Date of Electronic Publication: 2024 Sep 09.

Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management: A PIONEER Analysis Based on Big Data.

Autor: Gandaglia G; Guidelines Office, European Association of Urology, Arnhem, The Netherlands; Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy. Electronic address: Gandaglia.giorgio@hsr.it., Pellegrino F; Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy., Golozar A; Odysseus Data Services, New York, NY, USA; OHDSI Center, Northeastern University, Boston, MA, USA., De Meulder B; Association EISBM, Vourles, France., Abbott T; Astellas Pharma, Inc., Northbrook, IL, USA., Achtman A; The Movember Foundation, Melbourne, Australia., Imran Omar M; Guidelines Office, European Association of Urology, Arnhem, The Netherlands; Academic Urology Unit, University of Aberdeen, Scotland, UK., Alshammari T; Riyadh Elm University, Riyadh, Saudi Arabia., Areia C; University of Oxford, Oxford, UK., Asiimwe A; Bayer AG, Berlin, Germany., Beyer K; Translational Oncology and Urology Research, King's College London, London, UK., Bjartell A; Department of Translational Medicine, Lund University, Lund, Sweden., Campi R; Guidelines Office, European Association of Urology, Arnhem, The Netherlands; Unit of Urological Robotic Surgery and Renal Transplantation, University of Florence, Careggi Hospital, Florence, Italy; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Cornford P; Liverpool University Hospitals, Liverpool, UK., Falconer T; Department of Biomedical Informatics, Columbia University, New York, NY, USA., Feng Q; Astellas Pharma, Inc., Northbrook, IL, USA., Gong M; Nanfang Hospital, Southern Medical University, Guangzhou, China; DHC Technologies, Beijing, China., Herrera R; Bayer AG, Berlin, Germany., Hughes N; Epidemiology, Janssen R&D, Belgium., Hulsen T; Philips Research, Department of Hospital Services & Informatics, Eindhoven, The Netherlands., Kinnaird A; University of Alberta, Edmonton, Canada., Lai LYH; University of Manchester, Manchester, UK., Maresca G; Department of Urology, NHS Grampian, Scotland, UK., Mottet N; Guidelines Office, European Association of Urology, Arnhem, The Netherlands., Oja M; Institute of Computer Science, University of Tartu, Tartu, Estonia; STACC, Tartu, Estonia., Prinsen P; Netherlands Comprehensive Cancer Organization, Eindhoven, The Netherlands., Reich C; IQVIA, London, UK., Remmers S; Erasmus University Medical Centre, Cancer Institute, Rotterdam, The Netherlands., Roobol MJ; Erasmus University Medical Centre, Cancer Institute, Rotterdam, The Netherlands., Sakalis V; Department of Urology, General Hospital of Thessaloniki Agios Pavlos, Thessaloniki, Greece., Seager S; RWS, IQVIA, Durham, NC, USA., Smith EJ; Guidelines Office, European Association of Urology, Arnhem, The Netherlands., Snijder R; Astellas Pharma, Inc., Northbrook, IL, USA., Steinbeisser C; Bayer AG, Berlin, Germany., Thurin NH; INSERM CIC-P 1401, Bordeaux PharmacoEpi, Université de Bordeaux, Bordeaux, France., Hijazy A; Association EISBM, Vourles, France., van Bochove K; The Hyve, Utrecht, The Netherlands., Van den Bergh RCN; St Antonius Hospital, Utrecht, The Netherlands., Van Hemelrijck M; Translational Oncology and Urology Research, King's College London, London, UK., Willemse PP; Guidelines Office, European Association of Urology, Arnhem, The Netherlands; Department of Urology, Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands., Williams AE; The Institute for Clinical Research and Health Policy Studies at Tufts Medical Center, Boston, MA, USA., Zounemat Kermani N; Department of Computing, Data Science Institute, Imperial College London, London, England., Evans-Axelsson S; Bayer AG, Berlin, Germany., Briganti A; Guidelines Office, European Association of Urology, Arnhem, The Netherlands; Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy., N'Dow J; Guidelines Office, European Association of Urology, Arnhem, The Netherlands; Academic Urology Unit, University of Aberdeen, Scotland, UK.

Publikováno v: European urology [Eur Urol] 2024 May; Vol. 85 (5), pp. 457-465. Date of Electronic Publication: 2023 Jul 05.

From big data to better patient outcomes.

Autor: Hulsen T; Department of Hospital Services & Informatics, Philips Research, Eindhoven, The Netherlands., Friedecký D; Department of Clinical Biochemistry, Laboratory for Inherited Metabolic Disorders, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacký University in Olomouc, Olomouc, Czech Republic., Renz H; Institute of Laboratory Medicine, member of the German Center for Lung Research (DZL), and the Universities of Giessen and Marburg Lung Center (UGMLC), Philipps University Marburg, Marburg, Germany.; Department of Clinical Immunology and Allergy, Laboratory of Immunopathology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Melis E; Ortho Clinical Diagnostics, Zaventem, Belgium., Vermeersch P; Clinical Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.; Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.; European Federation of Clinical Chemistry and Laboratory Medicine (EFLM), Milan, Italy., Fernandez-Calle P; European Federation of Clinical Chemistry and Laboratory Medicine (EFLM), Milan, Italy.; Department of Laboratory Medicine, Hospital Universitario La Paz, Madrid, Spain.

Publikováno v: Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2022 Dec 22; Vol. 61 (4), pp. 580-586. Date of Electronic Publication: 2022 Dec 22 (Print Publication: 2023).

Autor: Hulsen T; Data Science & AI Engineering, Philips, High Tech Campus 34, 5656AE Eindhoven, Países Bajos.

Publikováno v: Advances in laboratory medicine [Adv Lab Med] 2024 Feb 19; Vol. 5 (2), pp. 166-172. Date of Electronic Publication: 2024 Feb 19 (Print Publication: 2024).

Applications of the metaverse in medicine and healthcare.

Autor: Hulsen T; Data Science & AI Engineering, Philips, Eindhoven, The Netherlands.

Publikováno v: Advances in laboratory medicine [Adv Lab Med] 2023 Dec 29; Vol. 5 (2), pp. 159-165. Date of Electronic Publication: 2023 Dec 29 (Print Publication: 2024).